# Raed Al-Rajabi – FDA Inspection, Mar 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/raed-al-rajabi/c3215eb6-f6bd-4c45-b25e-26c447aaaeaa
Source feed: FDA_Inspections

> FDA inspection 1309920 of Raed Al-Rajabi, March 27, 2026. 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309920
- Company Name: Raed Al-Rajabi
- Inspection Date: 2026-03-27
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1119599 - 2020-02-07

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/gavin-w-pierce/dfc6cdb8-2a63-42f4-8a19-6d394d16ee4d)

Company: https://www.keypedia.com/companies/raed-al-rajabi/7c2dcb28-343b-4a22-ba6f-68ec524baad9

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79
